PHGDH and neoplasm: Indeed, several preclinical trials have proven that the targeted inhibition of PHGDH with small molecule inhibitors disrupts the serine synthesis pathway and restricts tumor growth and metastasis (Mullarky et al., 2016; Pacold et al., 2016; Ngo et al., 2020).